- Report
- July 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- May 2024
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- May 2024
- 184 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- May 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- May 2024
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- May 2024
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2025
- 114 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- July 2024
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1373EUR$1,500USD£1,167GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2746EUR$3,000USD£2,334GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2746EUR$3,000USD£2,334GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1831EUR$2,000USD£1,556GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2746EUR$3,000USD£2,334GBP
- Drug Pipelines
- April 2025
- 200 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €1373EUR$1,500USD£1,167GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1373EUR$1,500USD£1,167GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more